However, treatments aimed at reducing elevated leptin levels, such as Metreleptin, leptin-sensitising medications, soluble leptin receptors, and leptin receptor antagonists, may complement efforts to raise adiponectin levels in the treatment of obesity-related diseases [77,78,79]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.